Ex-Valeant CEO sells shares for nearly $100 million
Former Valeant CEO Michael Pearson sold nearly five million shares and options for $96.8 million from June 30 through July 5, CNBC reports. Pearson left Valeant in late April after the company received criticism for significantly increasing the prices of its medications.
On May 31, Valeant announced that Pearson would receive $9 million as part of a severance agreement.
Read the CNBC article below.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.